{"content":"<li class=\"n-box-item date-title\" data-end=\"1377403199\" data-start=\"1377316800\" data-txt=\"Friday, December 20, 2019\">Saturday, August 24, 2013</li><li class=\"n-box-item sa-box-item\" data-id=\"1242182\" data-ts=\"1377374048\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ONXX\" target=\"_blank\">ONXX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1242182-nyt-amgen-close-to-buying-onyx-for-125-share\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NYT: Amgen close to buying Onyx for $125/share</a></h4><ul>\n<li>\n<a href=\"http://dealbook.nytimes.com/2013/08/24/amgen-said-to-be-near-a-deal-to-buy-onyx/?_r=0\" target=\"_blank\">The paper adds</a> a deal could be \"announced as soon as Monday,\" but cautions \"talks are ongoing and could still fall apart.\"</li>\n<li>The reported price would represent a 7% premium to Onyx's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ONXX\" title=\"ONYX Pharmaceuticals, Inc.\">ONXX</a>) Friday close of $116.96.</li>\n<li>Amgen (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AMGN\" title=\"Amgen Inc.\">AMGN</a>) reportedly <a href=\"https://seekingalpha.com/currents/post/1241092\" target=\"_blank\">revised its bid </a>from a prior $130/share after failing to obtain trial data related to Onyx's Kyprolis blood-cancer drug. The company is still paying a steep 10.5x 2014E sales.</li>\n<li><a href=\"https://seekingalpha.com/currents/search?query=amgn%20onxx\" target=\"_blank\">More on Amgen/Onyx</a></li>\n<li>\n<strong>Update:</strong> The <em>WSJ</em> <a href=\"http://online.wsj.com/article/SB10001424127887323665504579033211125063536.html\" target=\"_blank\">also reports</a> a $125/share deal is close. Its sources think a deal \"is likely to be announced Monday, if not sooner.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1242182\" data-linked=\"NYT: Amgen close to buying Onyx for $125/share\" data-tweet=\"$ONXX $ONXX $AMGN - NYT: Amgen close to buying Onyx for $125/share https://seekingalpha.com/news/1242182-nyt-amgen-close-to-buying-onyx-for-125-share?source=tweet\" data-url=\"https://seekingalpha.com/news/1242182-nyt-amgen-close-to-buying-onyx-for-125-share\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":1,"message":null,"success":true,"today":{"start":1576818000,"end":1576904399,"str":"Friday, December 20, 2019"},"yesterday":{"start":1576731600,"end":1576817999}}